chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a licensed vocational nurse refers to a 14 year old male patient with acne and attention deficit/hyperactivity disorder (ADHD and a history of insomnia and no drug reactions or allergies who on 20-JUL-2011, was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL (lot number 669285/0691AA, Exp. Date: 17-AUG-2013) and on 08-AUG-2013, was vaccinated with the second dose of GARDASIL (lot number J002641, Exp. Date: 10-DEC-2015). Concomitant therapies included Sulfacetamide sodium, Clonidine, VENTOLIN HFA, RETIN-A MICRO GEL, and Benzoyl peroxide (+) Clindamycin phosphate. The nurse reported that on 15-AUG-2013, the patient's father called to the office regarding a lump in his son throat. The patient was seen in the office on 16-AUG-2013 and the physician diagnosed the patient with lymph node enlargement. Antibiotics, warm compress and Ibuprofen were given as a treatment for the experience. At the time of the report, the patient had not recovered. The relatedness for lymph node enlargement and GARDASIL was unknown. Additional information has been requested.
Information has been received from a doctor of pharmacy concerning her 13 month old healthy daughter who on 02Mar2004 or 03Mar2004 was vaccinated with varicella virus vaccine live. Concomitant therapy the same day included pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (PREVNAR) and tuberculin purified protein derivative (PPD Tine Test). On 13Mar2004 a blood test showed elevated levels of white cells, red cells, and platelets. The pt sought unspecified medical attention. There was no product quality complaint involved. Additional information has been requested.
Fatigue and  left arm soreness for 48 hours afterwards which resolved. Left arm swelling, redness, itching that started a week after the injection and has been going on for 60 hours now. Also, fatigue and sore throat that started 1/21/21 in the evening.
Narrative:  CT of head ordered to rule out intracranial pathology. Patient on Depakote--levels therapeutic.
Chills fever vomiting diarrhea trachacardia fatigue migraine weak dizziness aches muscle pain joint pain starting dash my after and 4 daysater still Sick
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild
Fatigue, pain, development of itchy sores on right side of body and back. Sensitivity in the breast to clothing in armpit area, itching in that same area and small punctate bumps on the breast. Itching on backs of legs, upper arms and back. Hair follicle density seems to have decreased as well.
8cm erythematous wheal, left arm with warmth X 24 hours, post vax of Hep-B. Treated with Benadryl and warm compresses.
Full body muscle aches, including stomach cramps and headache. Fatigue, chills and low grade fever
Fever; Sore neck; Dry lips; Bleeding lips; Chapped lips; Sore eyes; Tired; Sore arm; Menstrual cramps; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11May2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included corneal transplant and sulfonamide allergy. Concomitant medication included birth control (unspecified). The patient previously took Codeine and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11May2021 at 17:00, the patient experienced fever, sore neck, dry/chapped/bleeding lips, gooey sore eyes, tired, sore arm and menstrual cramps (no menses). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the adverse events and included treatment with TYLENOL. The clinical outcome of the events fever, sore neck, dry lips, chapped lips, bleeding lips, sore eyes, tired, sore arm and menstrual cramps (no menses) was resolved on an unknown date in May2021  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information expected.
Per telephone call, injection site very red and swollen and hot to touch. Advised to use ice and Tylenol and Motrin as needed.
The patient reported that her blood glucose level began to rise shortly following receiving the vaccine. The patient continued to monitor her blood glucose level and administer the correct amount of insulin following the  insulin titration outline.  The patient avoided eating large meals throughout the day.  The patient reported that her insulin levels began to decrease approximately 10-12 hours following the vaccine administration. The patient reported that she never felt the effects or symptoms of the elevated blood glucose.  The patient noticed the spike in her blood glucose due to the routine monitoring of her blood glucose.
She feels achy; She felt tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (She feels achy) and FATIGUE (She felt tired) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced FATIGUE (She felt tired). On 16-Mar-2021, the patient experienced PAIN (She feels achy). At the time of the report, PAIN (She feels achy) and FATIGUE (She felt tired) outcome was unknown.            No relevant concomitant medications were provided.  No treatment information was provided.
Please not pharmacy administered the vaccine. I provided my PCP info. Extreme fatigue, lack of appetite, chills began 12 hours after vaccination and lasted approximately 12 hours.
She got her vaccine, she was okay, went to another store and went shopping asked that pharmacy to look at it, and she was told that it was ok.   The next day, yesterday she saw a red rash about 3" below the injection site that was hot to the touch and swollen.  She has been icing it every 12 hours.  She took a Benadryl and Tylenol 2 500 mg.  She woke up in the middle of the night her left hand was numb, moved it and it disappeared.  Her temp has been low in the 97.4-97.7 range.  Her neighbor is a NP and she asked her what she thought, and she said it may be due to the injection itself, and told her to take Benadryl and that maybe the Tylenol was too much but to continue taking the Benadryl.  She also called the pharmacy and they told her that it was in the right spot.  The NP told her that it was higher than it should have been.  It looks pretty much the same today as it did yesterday.  The rash is about 2" x 3".  It has not gotten worse, and has not gotten better.  The rest of her body seems ok, it's just her left arm.    When she rotates her arm from the top to the side she feels some pain in the shoulder area, which she did not feel the other day.
This spontaneous report as received from a registered nurse. The  reporter reported that an unspecified physician office, VAQTA, RECOMBIVAX and GARDASIL were exposed to 33F for 70 temperature excursions which tolerated 1173 hours out of range. She stated that during this time, these doses may have been administered to an unspecified number of patients. No adverse effects reported. The reporter stated she did not have any patient information. The reporter stated that at a different unspecified physician's office ROTATEQ, VAQTA, RECOMBIVAX and GARDASIL were exposed to 34F for 317 hours (13 days) and then they were exposed to 48F for 63 hours. The reporter stated that these doses may have been administered to an unspecified number of patients. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
PT HAD RED RASH ON UPPER INNER LEFT ARM. 0 ITCHING OR SOB. VS @ 1605  BP 130/81  PR 106  02SAT 96          1615  BP 125/81  PR 106  02SAT 96
none adverse reaction or side effects experienced; pneumococcal vaccine administered on 17-SEP-2015 and on 26-NOV-2016; This spontaneous report as received from a lawyer refers to a 69-year-old female patient. The patient's concurrent conditions, medical history and concomitant therapy were captured in case MARRS # 2009USA003874.  The patient was vaccinated with pneumococcal vaccine, polyvalent (manufacturer unknown) on 17-SEP-2015 and on 26-NOV-2016 (lot#, expiration date, dose, route of administration and anatomical location were not reported). None adverse reaction or side effects were experienced by the patient.  This is one of 2 reports concerning the same patient.; Sender's Comments:  US-009507513-2009USA003874:
Rash, decreased sensation and decreased strength in the left arm.  7/7/09 Hospital records received DOS 5/11/09 to 5/15/09. Assessment: Disturbed sensory perception, mononeuropathy. Patient presented with blotchy streaked erythematous left upper arm rash, raised nodule. Left arm numbness C5-T1 dermatomes. Complaints of tingling and pain. Swelling. No sensation to sharp or dull touch. Episode of chest pain and shortness of breath.  7/20/09 ICD-9 Codes: 354.9, 782.1, 346.90, 781.3, 781.2, 787.91, 723.1, 789.00, 782.0
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 30Sep2022 at 13:30 as dose 5 (booster), single (Lot number: GJ2524) at the age of 59 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient is treated with Paxlovid from 20Mar2023 to 24Mar2023 for COVID-19.
After I took the first vaccine shot at Facility I started having issues with my heat having PVC's after I took the second shot I got pneumonia and was out of work for several days.  Later I started having issues driving and found out that the shot has caused my eyes and brain not to connect so I am unable to drive up and down hills.  I have been under a doctor's care since July of 2022.
UTI symptoms; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI symptoms) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included UTI.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (UTI symptoms). The patient was treated with AZITHROMYCIN (AZO) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, URINARY TRACT INFECTION (UTI symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided
not feeling myself; sore arm; bad headache; nausea; chills; low grade fever; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm), HEADACHE (bad headache), NAUSEA (nausea), CHILLS (chills) and PYREXIA (low grade fever) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), HEADACHE (bad headache), NAUSEA (nausea), CHILLS (chills) and PYREXIA (low grade fever). On 26-Jan-2021, the patient experienced FEELING ABNORMAL (not feeling myself). On 26-Jan-2021, PAIN IN EXTREMITY (sore arm), NAUSEA (nausea), CHILLS (chills) and PYREXIA (low grade fever) had resolved. At the time of the report, HEADACHE (bad headache) had not resolved and FEELING ABNORMAL (not feeling myself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment medication included  Tylenol. But it was not working..
Blood clots in lung and leg; Blood clots in lung and leg; Dizziness; Weakness; Headache; shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 36-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm on 29Apr2021 16:00 (Batch/Lot Number: EW0162) as 2nd dose, single dose for COVID-19 immunization. The patient received the first dose of COVID-19 vaccine on 08Apr2021 17:45 left arm for COVID-19 immunization. Medical history included fibromyalgia and had covid-19 prior to vaccination. Concomitant medications included gabapentin; ethinylestradiol, norgestimate (ORTHO-CYCLEN); and diclofenac sodium (DICLOFENAC SODIUM); all taken for an unspecified indication, start and stop date were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Apr2021 05:00, the patient had blood clots in lung and leg, dizziness, weakness, headache (still after a month) and shortness of breath. As a result of the events, the patient visited doctor or other healthcare professional and has been to the emergency room. The events required hospitalization and was considered a life-threatening illness (immediate risk of death from the event). The patient was hospitalized for two days. The patient was put on blood thinners as treatment for the events. The patient has not recovered from the events.
R arm swollen, warm to touch area with rash 3cm surrounding injection site with tenderness
Approximately 15 minutes after vaccination, as patient was walking out of examination room, he said "I don't feel too well," became unsteady on his feet, was caught by this nurse and another staff member and was seated on a chair; episode observed by MD, cold compress applied to back of neck and on forehead, vital signs taken at five minute intervals, discharged to the care of mother.
This spontaneous pregnancy report as received from a physician refers to a 20 year old female patient with no known drug allergies and seizures. The patient's concomitant medications were not provided. On 30-NOV-2016, the patient was vaccinated with GARDASIL 9, dose 1, lot # M031557 and expiration date: 07-APR-2019 (route was not provided). On 30-JAN-2017, the patient was vaccinated with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (route, lot # and expiration date were not provided). The patient was found to be pregnant on 30-JAN-2017 which was confirmed by an unspecified pregnancy test and through an ultrasound on 14-FEB-2017. The patient's was currently at 9 weeks gestation. The date of last menstrual period and the expected date of delivery were not provided. No further information was provided. Additional information has been requested.
14 hrs after receiving the 2nd Moderna vaccine..she noticed twitching of random areas of her body and face..not all at once but was constantly twitching at one place or another.  No other symptoms..no fever..no HA..nothing unusual about injection site..Does have some muscle aches and fatigue which she expected.  Also mentioned some loss of balance when trying to walk.  Her symptoms have been constant for several hours today and not going away.
Swollen body, rash, fever, joint, bone and muscle pain and stiffness. Hypertension. Up to day still getting treatment in some conditions.
The morninfg after recieving Adacel, patient reported diffuse myalgias in back, arms, legs. Treated with ibuprofen 800mg Q8 hours.
No adverse event; Patient administered a bivalent vaccine on January 9, 2023, instead of a monovalent vaccine for the second dose in Moderna primary series; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient administered a bivalent vaccine on January 9, 2023, instead of a monovalent vaccine for the second dose in Moderna primary series) and NO ADVERSE EVENT (No adverse event) in a 34-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 043H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jan-2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 09-Jan-2023, the patient experienced WRONG PRODUCT ADMINISTERED (Patient administered a bivalent vaccine on January 9, 2023, instead of a monovalent vaccine for the second dose in Moderna primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient administered a bivalent vaccine on January 9, 2023, instead of a monovalent vaccine for the second dose in Moderna primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient administered a bivalent vaccine on January 9, 2023, instead of a monovalent vaccine for the second dose in Moderna primary series).    Concomitant product information was not provided by the reporter.   Treatment information was not provided.
I have taken birth control pills consistently for the past 9 years. I take each pill at 8pm every night (I am very meticulous). I have never experienced spotting between my cycles until 24 hours after I received my second dose of the Pfizer covid-19 vaccine.  I have not changed anything in my daily routine except getting the Pfizer covid-19 vaccine When I experienced bleeding I was on week 2, day 2 of my active birth control pills, and was not scheduled to start my period for another week and 5 days.  I am now on my third week of pills and I still have my period (it has been 6 days now).  I contacted my primary doctor and notified her of my experience and she instructed me to report the event to VAERS.
One minute after receiving the vaccine, patient experienced dizziness, dry mouth, sweating, and low bp. I checked his bp at 121p and it was 97/51 pulse 51; rechecked at 130p and it was 106/60 pulse 56. I gave him water, icepacks, a glucose tablet and had him sit on the bench while I monitored for any other symptoms. He recovered after 10 minutes and walked out on his own power.
Family took patient to walk-in vaccine clinic. Obtained #2 Hepatitis A dose, #4 Pneumococcal dose (each in left thigh), and Influenza Split virus dose (right thigh). Patient was laughing, eating, playful, when sunshine into house illuminated fine bumps on right side of chest at 4:30 PM. Mother took rectal temp of 99.9 degrees F. At 6:30 PM she gave BENADRYL (5ml of 12.5 mg); at 8:30 PM Ibuprofen 100 mg.
Pt states she developed muscle aches about 12 hours after receiving the vaccine and the muscle aches continued for 24 hours.  She states the muscle aches has resolved now.
This spontaneous report as received from a medical assistant refers to a 4 month old male patient. No information regarding the patients' pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 27-FEB-2017 the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # M016238 and expiration date: 07-DEC-2017), (dosing regimen and frequency unknown) orally for prophylaxis (product storage error). The ROTATEQ vaccines were stored between 44 Fahrenheit degrees (F) and 77 F for 45 minutes. There was no previous temperature excursion. There was no previous temperature excursion. The medical assistant also stated that a data logger was involved on 23-OCT-2017 that prompted her to call the company. This is one of the many reports from the same source. Sender's Comments: US-009507513-1710USA012197; US-009507513-1805USA007925; US-009507513-1805USA007926; US-009507513-1805USA007928; US-009507513-1805USA007929.
Cough, sneezing, sore throat, aches, elevated temp (but not above normal of 98.6).
Patient hospitalized overnight for afebrile seizure. Patient give ATIVAN & KEPPRA in ER. Released with no meds.
I received the smallpox vaccine on 23 Jan 03.  This was a primary vaccination for smallpox.  The site followed the normal stages that have been outlined by the CDC. On or about 6 Feb I noticed that I was having increased itching.  Over the past few weeks I had some increased itching but attributed it to the winter weather and dry skin.  On this day I looked closer at the areas that were itching and noticed several raised red bumps.  These bumps were on my inner legs and under my arms.  About a day after noticing these bumps some actually started to look like the what ringworm looks like. This resembled the generalized vaccinia the most.  I reported to the physicians and was told to take Benadryl and was prescribed Atarax for the itching.  It has been about six days since first noticing the bumps and the original bumps appear to be getting better.  There have been other bumps that have developed on other areas of my body (lower legs, arms).  The itching has subsided in the original areas but as new bumps appear they do itch quite a lot.
Patient was "not feeling right" when walking back to chair in waiting room, patient lost consciousness and fell backwards. Patient then was transported by family to the emergency room.
pt recv ax 14AUG96 & 17AUG96 pt exp a fever of 104;fever alleviated w/APAP & ATB;
This spontaneous report as received from a Certified Medical Assistant refers to a patient of unknown age and gender. On 27-APR-2015, the patient was vaccinated with one dose of (Oka-Merck) PROQUAD that had been improperly stored (subcutaneous, lot # K025760, expiry: 08-JUN-2016, dose not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.